Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Graham E Searle

Showing results (21-30 of 40) with videos related to

Pageof 4
Sort By:
Movement Disorders : Official Journal of the Movement Disorder Society|November 15, 2025
Safety, Tolerability, Pharmacokinetics, and Brain Target Occupancy of the OGA Inhibitor ASN90 in Healthy ParticipantsRolf Pokorny, J Michael Ryan, Khalid Abd-Elaziz, et al.
Synapse (New York, N.Y.)|February 17, 2009
Positron emission tomography imaging of amphetamine-induced dopamine release in the human cortex: a comparative evaluation of the high affinity dopamine D2/3 radiotracers [11C]FLB 457 and [11C]fallyprideRajesh Narendran, W Gordon Frankle, N Scott Mason, et al.
Cerebral Cortex (New York, N.Y. : 1991)|January 4, 2013
Connectivity-based functional analysis of dopamine release in the striatum using diffusion-weighted MRI and positron emission tomographyAndri C Tziortzi, Suzanne N Haber, Graham E Searle, et al.
Brain : a Journal of Neurology|July 23, 2015
Altered PDE10A expression detectable early before symptomatic onset in Huntington's diseaseFlavia Niccolini, Salman Haider, Tiago Reis Marques, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|June 25, 2025
EC<sub>50</sub> images reveal reproducible spatial variation in drug affinity across single- and repeat-dose occupancy studiesAlaaddin Ibrahimy, Su Jin Kim, Mark E Schmidt, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|January 29, 2014
In vivo imaging of cerebral dopamine D3 receptors in alcoholismDavid Erritzoe, Andri Tziortzi, David Bargiela, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|September 1, 2011
Within-subject comparison of [(11)C]-(+)-PHNO and [(11)C]raclopride sensitivity to acute amphetamine challenge in healthy humansPaul Shotbolt, Andri C Tziortzi, Graham E Searle, et al.
EJNMMI Research|May 16, 2015
Lapatinib access into normal brain and brain metastases in patients with Her-2 overexpressing breast cancerAzeem Saleem, Graham E Searle, Laura M Kenny, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|October 22, 2021
Endogenous dopamine release in the human brain as a pharmacodynamic biomarker: evaluation of the new GPR139 agonist TAK-041 with [<sup>11</sup>C]PHNO PETEugenii A Rabiner, Tolga Uz, Ayla Mansur, et al.
Journal of Psychopharmacology (Oxford, England)|January 17, 2014
Characterising the plasma-target occupancy relationship of the neurokinin antagonist GSK1144814 with PETKhanum Ridler, Roger N Gunn, Graham E Searle, et al.
Pageof 4

Showing results (21-30 of 40) with videos related to

Sort By:
Pageof 4
Movement Disorders : Official Journal of the Movement Disorder Society|November 15, 2025
Safety, Tolerability, Pharmacokinetics, and Brain Target Occupancy of the OGA Inhibitor ASN90 in Healthy ParticipantsRolf Pokorny, J Michael Ryan, Khalid Abd-Elaziz, et al.
Synapse (New York, N.Y.)|February 17, 2009
Positron emission tomography imaging of amphetamine-induced dopamine release in the human cortex: a comparative evaluation of the high affinity dopamine D2/3 radiotracers [11C]FLB 457 and [11C]fallyprideRajesh Narendran, W Gordon Frankle, N Scott Mason, et al.
Cerebral Cortex (New York, N.Y. : 1991)|January 4, 2013
Connectivity-based functional analysis of dopamine release in the striatum using diffusion-weighted MRI and positron emission tomographyAndri C Tziortzi, Suzanne N Haber, Graham E Searle, et al.
Brain : a Journal of Neurology|July 23, 2015
Altered PDE10A expression detectable early before symptomatic onset in Huntington's diseaseFlavia Niccolini, Salman Haider, Tiago Reis Marques, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|June 25, 2025
EC<sub>50</sub> images reveal reproducible spatial variation in drug affinity across single- and repeat-dose occupancy studiesAlaaddin Ibrahimy, Su Jin Kim, Mark E Schmidt, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|January 29, 2014
In vivo imaging of cerebral dopamine D3 receptors in alcoholismDavid Erritzoe, Andri Tziortzi, David Bargiela, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|September 1, 2011
Within-subject comparison of [(11)C]-(+)-PHNO and [(11)C]raclopride sensitivity to acute amphetamine challenge in healthy humansPaul Shotbolt, Andri C Tziortzi, Graham E Searle, et al.
EJNMMI Research|May 16, 2015
Lapatinib access into normal brain and brain metastases in patients with Her-2 overexpressing breast cancerAzeem Saleem, Graham E Searle, Laura M Kenny, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|October 22, 2021
Endogenous dopamine release in the human brain as a pharmacodynamic biomarker: evaluation of the new GPR139 agonist TAK-041 with [<sup>11</sup>C]PHNO PETEugenii A Rabiner, Tolga Uz, Ayla Mansur, et al.
Journal of Psychopharmacology (Oxford, England)|January 17, 2014
Characterising the plasma-target occupancy relationship of the neurokinin antagonist GSK1144814 with PETKhanum Ridler, Roger N Gunn, Graham E Searle, et al.
Pageof 4